Global efforts in the fight against COVID-19

Discover COVID-19 solutions and resources

A COVID-19 test for every situation

From the onset of the novel coronavirus outbreak, QIAGEN’s dedicated global teams have been working around the clock to ensure the availability of existing testing solutions and to develop new SARS-CoV-2 tests to address international testing needs.

Today, we offer a comprehensive portfolio of SARS-CoV-2 testing solutions on the market, covering the needs of clinical and research customers, from manual to automated sample processing, low to high throughput, single-plex to multi-plex, and from active infection testing to the detection of previous viral exposure.

Francesca DiPasquale, QIAGEN employee, mask, coronavirus

Confronting emerging COVID-19 variants

Two scientist in a lab, QIAsymphony, interacting, Handbook, Guidance, Julian Phollips, Chaimae Safi, mask, wearing masks, Labcoats

During this unprecedented COVID-19 pandemic, data on novel SARS-CoV-2 variants with potentially increased transmissibility is rapidly developing. Confronting these new variants demands constant surveillance on diagnostic impact and accelerated development of innovative research technologies. Learn how our R&D and medical teams are working around the clock to empower your research and diagnostic labs.

Innovation-led NGS solutions and integrated bioinformatics
Gain greater insights into the epidemiology of SARS-CoV-2 with a full spectrum of NGS solutions and integrated bioinformatics pipelines.
Find out more
Understanding the impact on test results
Stay up to date on our continuous surveillance assessing the impact of mutations on assay sensitivity. (Updated July 2021)
download file

Latest
–
new solutions, webinars and updates

Quick pivot enables lab to serve community during pandemic

Great Lakes Labs president and CEO Michelle Volk redirected her lab’s focus from forensics to clinical medicine in reaction to the COVID-19 pandemic to provide her community with rapid, accurate testing, and peace of mind.

Read their story

QIAGEN offers new antigen solution
The mö-screen Corona Antigen Test is now available through QIAGEN.
LEARN MORE
Discover a 50% faster, high-throughput SARS-CoV-2 NGS solution
Accelerate SARS-CoV-2 genomic surveillance and develop an accurate picture of circulating variants with ultrafast whole viral genome sequencing using QIAseq DIRECT SARS-CoV-2 Kits.
Explore now
QIAGEN adds kits for wastewater testing to COVID-19 portfolio
QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing.
PRESS RELEASE
QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 Test
The artus Prep&Amp test offers up to threefold increase in daily lab testing capacity.
PRESS RELEASE

Hospital floor, person with mask and protection suit, walking, unfixing the mask, two more people in the back, 06/2015, (General, Photography, Doctor/Physician, Hospital)

Diagnostic testing for COVID-19

We have developed a comprehensive portfolio of COVID-19 diagnostic testing solutions including targeted and multiplex PCR detection and rapid antibody tests. We also supports several testing protocols by providing test components and mid- to high-throughput automation solutions.

DIAGNOSTIC SOLUTIONS

COVID-19 research solutions

Pandemics require accelerated development of innovative technologies to provide rapid and effective responses. QIAGEN supports scientists seeking to better understand the SARS-CoV-2 virus with research tools. Our portfolio includes a full spectrum of our high-performance NGS solutions and integrated bioinformatics pipelines that collectively drive a greater understanding of the multiple facets of SARS-CoV-2 biology.

Research Solutions

people working in a laboratory, conversation, talk

Latest news on QIAGEN’s COVID-19 efforts

At QIAGEN we work tirelessly on novel approaches to support healthcare workers and scientists in their fight against COVID-19.

We have dramatically scaled up production, moving to 24 hour, seven-day-a-week operations at our manufacturing sites. Stay up-to-date with our latest developments here.

LATEST UPDATES

icon-support

How can we support your lab?

Reach a specialist about SARS-CoV-2 resources.

Let us know

möLab GmbH is the manufacturer of the mö-screen Corona Antigen Test. QIAGEN is a distributor.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.